|Bid Price||-||Offer Price||-|
|Mid Price||GBX 125.30||Day Change||GBX -0.20 (-0.16%)|
|Price Date||15 Jan 2018||Crown Rating|
|Shares Class||Inc.||Yield||2.10 %|
|Total Expense Ratio||0.75||Fund Size||19,427,900.00|
|Launch Date||29/12/2006||Standard Initial Charge (%)||0.00|
|Annual Management Charge (%)||0.65||Sector||IMA UK Equity Income|
|Min Investment (£)||100,000,000.00||Total Expense Ratio (%)||0.75|
|ISIN||GB00BVCXMD05||Min TopUp (£)||0.00|
To provide capital growth by investing principally in UK companies, including those we consider to be ‘special situations’. Such ‘special situations’ can exist where companies are out of favour, misunderstood or where management changes or takeovers are expected.
Mark is an Investment Director and Head of UK Equities. He also undertakes global research on the healthcare sector. In 2002, Mark graduated from Oxford University in Classics before qualifying as a solicitor at Allen & Overy in the Private Equity group.